TRAF5 is a critical mediator of in vitro signals and in vivo functions of LMP1, the viral oncogenic mimic of CD40

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 40, 2009, Pages 17140-17145

  Kraus, Zachary J ^a   Nakano, Hiroyasu ^b   Bishop, Gail A ^a,c,d  

^a UNIVERSITY OF IOWA   (United States)

^b JUNTENDO UNIVERSITY   (Japan)

^c UNIVERSITY OF IOWA   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

B lymphocyte; Latent membrane protein 1; Lymphocyte activation; TNF receptor superfamily; TNF receptor associated factor

Indexed keywords

AUTOANTIBODY; CD40 ANTIGEN; INTERLEUKIN 6; LATENT MEMBRANE PROTEIN 1; PROTEIN C JUN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 5;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY BLOOD LEVEL; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; LYMPHADENOPATHY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; MOLECULAR MIMICRY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SPLENOMEGALY; VIRUS ONCOGENE;

ANIMALS; ANTIBODIES, ANTINUCLEAR; ANTIGENS, CD40; B-LYMPHOCYTES; BLOTTING, WESTERN; ENZYME ACTIVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; INTERLEUKIN-6; LYMPH NODES; MALE; MAP KINASE KINASE 4; MAP KINASE KINASE KINASES; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; SPLEEN; TIME FACTORS; TNF RECEPTOR-ASSOCIATED FACTOR 5; VIRAL MATRIX PROTEINS;

MUS; MUS MUSCULUS;

EID: 70350134950     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0903786106     Document Type: Article

References (34)

1. Fennewald S, van Santen V, Kieff E (1984) Nucleotide sequence of anmRNAtranscribed in latent growth-transforming virus infection indicates that itmayencode amembrane protein. J Virol 51:411-419. (Pubitemid 14091430)
2. Liebowitz D, Wang D, Kieff E (1986) Orientation and patching of the latent infection membrane protein encoded by Epstein-Barr virus. J Virol 58:233-237. (Pubitemid 16021984)
3. Brown KD, Hostager BS, Bishop GA (2001) Differential signaling and tumor necrosis factor receptor-associated factor (TRAF) degradation mediated by CD40 and the Epstein-Barr virus oncoprotein latent membrane protein 1 (LMP1). J Exp Med 193:943-954.
4. Stunz LL, et al. (2004) Expression of the cytoplasmic tail of LMP1 in mice induces hyperactivation of B lymphocytes and disordered lymphoid architecture. Immunity 21:255-266.
5. Busch LK, Bishop GA (1999) The EBV transforming protein, latent membrane protein 1, mimics and cooperates with CD40 signaling in B lymphocytes. J Immunol 162:2555-2561.
6. Dirmeier U, et al. (2005) Latent membrane protein 1 of Epstein-Barr virus coordinately regulates proliferation with control of apoptosis. 24:1711-1717.
7. Rastelli J, et al. (2008) LMP1 signaling can replace CD40 signaling in B cells in vivo and has unique features of inducing class-switch recombination to IgG1. Blood 111:1448-1455. (Pubitemid 351213432)
8. Vockerodt M, et al. (2008) The Epstein-Barr virus oncoprotein, latent membrane protein-1, reprograms germinal centre B cells towards a Hodgkin's Reed-Sternberglike phenotype. J Pathol 216:83-92.
9. Homig-Holzel C, et al. (2008) Constitutive CD40 signaling in B cells selectively activates the noncanonical NF-κB pathway and promotes lymphomagenesis. J Exp Med 205:1317-1329. (Pubitemid 351831489)
10. Xie P, Hostager BS, Munroe ME,Moore CR, BishopGA(2006) Cooperation between TNF receptor-associated factors 1 and 2 in CD40 signaling. J Immunol 176:5388-5400.
11. Xie P, Hostager BS, Bishop GA (2004) Requirement for TRAF3 in signaling by LMP1 but not CD40 in B lymphocytes. J Exp Med 199:661-671. (Pubitemid 38316433)
12. Devergne O, et al. (1998) Role of the TRAF binding site and NF-kappa B activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression. J Virol 72:7900-7908. (Pubitemid 28421781)
13. Xie P, Bishop GA (2004) Roles of TNF receptor-associated factor 3 in signaling to B lymphocytes by carboxyl-terminal activating regions 1 and 2 of the EBV-encoded oncoprotein latent membrane protein 1. J Immunol 173:5546-5555. (Pubitemid 39392141)
14. Nakano H, et al. (1999) Targeted disruption of Traf5 gene causes defects in CD40- and CD27-mediated lymphocyte activation. Proc Natl Acad Sci USA 96:9803-9808. (Pubitemid 29398813)
15. Ishida TK, et al. (1996) TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling. Proc Natl Acad Sci USA 93:9437-9442.
16. Aizawa S, et al. (1997) Tumor necrosis factor receptor-associated factor (TRAF) 5 and TRAF2 are involved in CD30-mediated NFkappa B activation. J Biol Chem 272:2042-2045. (Pubitemid 27058475)
17. Akiba H, et al. (1998) CD27, a member of the tumor necrosis factor receptor superfamily, activates NF-kappaB and stress-activated protein kinase/c-Jun N-terminal kinase via TRAF2, TRAF5, and NF-kappaB-inducing kinase. J Biol Chem 273:13353-13358. (Pubitemid 28246911)
18. Naito Y, et al. (2007) Germinal center marker GL7 probes activation-dependent repression of N-glycolylneuraminic acid, a sialic acid species involved in the negative modulation of B-cell activation. Mol Cell Biol 27:3008-3022. (Pubitemid 46581314)
19. Baccam M, Woo S-Y, Vinson C, Bishop GA (2003) CD40-mediated transcriptional regulation of the IL-6 gene in B lymphocytes: Involvement of NF-κB, AP-1, and C/EBP. J Immunol 170:3099-3108. (Pubitemid 36302185)
20. Uemura N, et al. (2006) TAK1 is a component of the Epstein-Barr virus LMP1 complex and is essential for activation of JNK but not of NF-κB. J Biol Chem 281:7863-7872. (Pubitemid 43847402)
21. Wan J, et al. (2004) Elucidation of the c-Jun N-terminal kinase pathway mediated by Epstein-Barr virus-encoded latent membrane protein 1. Mol Cell Biol 24:192-199. (Pubitemid 38010047)
22. Thornburg NJ, et al. (2006) LMP1 signaling and activation of NF-kappaB in LMP1 transgenic mice. Oncogene 25:288-297. (Pubitemid 43083690)
23. HirofumiAmano, et al. (2005) Selective expansion of amonocyte subset expressing the CD11c dendritic cell marker in the Yaa model of systemic lupus erythematosus. Arthritis Rheum 52:2790-2798.
24. Maeda K, et al. (2009) Interleukin-6 aborts lymphopoiesis and elevates production of myeloid cells in systemic lupus erythematosus-prone B6.Sle1.Yaa animals. Blood 113:4534-4540.
25. Baccam M, Bishop GA (1999) Membrane-bound CD154, but not CD40-specific antibody, mediates NF-kappaB-independent IL-6 production in B cells. Eur J Immunol 29:3855-3866.
26. Ishihara K, Hirano T (2002) IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev 13:357-368, 2002.
27. Richards HB, et al. (1998) Interleukin 6 dependence of anti-DNA antibody production: Evidence for two pathways of autoantibody formation in pristane-induced lupus. J Exp Med 188:985-990.
28. Vanden Bush TJ, Bishop GA (2008) TLR7 and CD40 cooperate in IL-6 production via enhanced JNK and AP-1 activation. Eur J Immunol 38:400-409.
29. Qin J, et al. (2006) TLR8-mediated NF-κB and JNK activation are TAK1-independent and MEKK3-dependent. J Biol Chem 281:21013-21021. (Pubitemid 44115442)
30. Hostager BS, Haxhinasto SA, Rowland SL, Bishop GA (2003) Tumor necrosis factor receptor-associated factor 2 (TRAF2)-deficient B lymphocytes reveal novel roles for TRAF2 in CD40 signaling. J Biol Chem 278:45382-45390. (Pubitemid 37432675)
31. Herbst H, Samol J, Foss HD, Raff T, Niedobitek G (1997) Modulation of interleukin-6 expression in Hodgkin and Reed-Sternberg cells by Epstein-Barr virus. J Pathol 182:299-306. (Pubitemid 27285782)
32. Neri A, et al. (1991) Epstein-Barr virus infection precedes clonal expansion in Burkitt's and acquired immunodeficiency syndrome-associated lymphoma. Blood 77:1092-1095.
33. Brady G, MacArthur GJ, Farrell PJ (2007) Epstein Barr virus and Burkitt lymphoma. J Clin Pathol 60:1397-1402. (Pubitemid 350247257)
34. Kraus ZJ, Haring JS, Bishop GA (2008) TNF receptor-associated factor 5 is required for optimal T cell expansion and survival in response to infection. J Immunol 181:7800-7809.